Bayer (BAYRY)
(Delayed Data from OTC)
$7.26 USD
-0.11 (-1.49%)
Updated Apr 24, 2024 03:59 PM ET
4-Sell of 5 4
C Value A Growth C Momentum B VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 11% (224 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 2.10 | 9.99 |
Current Quarter Estimate | NA | 37.64 | 60.00 |
Year Ago Quarter Estimate | 0.79 | 11.39 | 52.54 |
Next Quarter Estimate | NA | 34.85 | 61.00 |
Next Year Estimate | 1.46 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -21.39 | 3.80 | 17.08 |
Next Year | 7.35 | 16.10 | 8.00 |
Last 5 Years | -0.90 | 3.00 | 8.10 |
Next 5 Years | NA | 11.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 4.28 | 15.53 |
Price/Book (MRQ) | 0.71 | 5.30 |
Price/Cash Flow (MRFY) | 1.92 | 10.16 |
Dividend Yield | 6.12% | 2.85% |
Net Profit Margin (TTM) | -6.31% | 45.26% |
Return on Equity (TTM) | 17.27% | 36.43% |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.